SCHEMBL4765237

SCHEMBL4765237

O=C(NCc1ccccc1)C(F)(F)F

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.61
MMP8 P22894 2/20 0.56
HDAC3 O15379 1/20 0.55
HDAC4 P56524 1/20 0.55
HDAC1 Q13547 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55
GAA P10253 1/20 0.53
TSHR P16473 2/20 0.53
ALDH1A1 P00352 3/20 0.53
MAPT P10636 1/20 0.53
CES1 P23141 1/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.51
OPRK1 P41145 1/20 0.51
EPHX1 P07099 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30471275 1.00 RIPK1 (0.61) RIPK1MMP8HDAC3HDAC4HDAC1
Alcohol SCHEMBL8617609 0.93 RIPK1 (0.63) RIPK1MMP8HDAC3HDAC4HDAC1
SCHEMBL28030188 0.91 RIPK1 (0.53) RIPK1MMP8HDAC3HDAC4HDAC1
SCHEMBL28707389 0.86 RIPK1 (0.59) RIPK1MMP8HDAC3HDAC4HDAC1
SCHEMBL24263394 0.85 RIPK1 (0.57) RIPK1MMP8HDAC3HDAC4HDAC1
SCHEMBL17792642 0.85 RIPK1 (0.57) RIPK1MMP8HDAC3HDAC4HDAC1
SCHEMBL1435285 0.83 KMT2A (0.61) MMP8HDAC6ALDH1A1KMT2AMEN1
SCHEMBL506307 0.82 MTOR (0.54) RIPK1HDAC6ALDH1A1SMN1; SMN2
SCHEMBL2054822 0.82 EPHX2 (0.50) RIPK1HDAC1HDAC6ALDH1A1KMT2A
SCHEMBL16714711 0.82 RIPK1 (0.54) RIPK1MMP8HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025087000-A1 ELECTROLYTE, BATTERY, AND ELECTRIC DEVICE 宁德时代新能源科技股份有限公司 2025-05-01 WO claimed
CN-119905655-A Electrolyte, battery and electric equipment 宁德时代新能源科技股份有限公司 2025-04-29 CN claimed
CN-108516957-A A kind of preparation method of amides compound 湖南大学 2018-09-11 CN claimed
WO-2025087000-A1 ELECTROLYTE, BATTERY, AND ELECTRIC DEVICE 宁德时代新能源科技股份有限公司 2025-05-01 WO disclosed
CN-119905655-A Electrolyte, battery and electric equipment 宁德时代新能源科技股份有限公司 2025-04-29 CN disclosed
US-20230137943-A1 PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS THE UNIVERSITY OF CHICAGO 2023-05-04 US disclosed
CN-109369506-B Method for selectively N-methylating secondary amide 广东石油化工学院 2022-05-31 CN disclosed
CN-109369506-A A kind of method of selective N-methylation second level amide 广东石油化工学院 2019-02-22 CN disclosed
CN-108516957-A A kind of preparation method of amides compound 湖南大学 2018-09-11 CN disclosed
EP-1390340-B1 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INST TECHNOLOGY (US) 2017-03-01 EP disclosed
US-20160303128-A1 PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS VIBLIOME THERAPEUTICS, LLC 2016-10-20 US disclosed
WO-1998035946-A1 4-AMINOALKOXY-1,3-DIHYDROBENZOIMIDAZOL-2-ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE AUTORECEPTOR (D2) AGONISTS AMERICAN HOME PRODUCTS CORPORATION (US) 1998-08-20 WO disclosed
EP-0759027-A1 BICYCLIC AMIDINE DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHETASE Astra Aktiebolag (SE) 1997-02-26 EP disclosed
WO-1997006158-A1 BICYCLIC AMIDINE DERIVATIVES USEFUL IN THERAPY ASTRA AKTIEBOLAG (SE) 1997-02-20 WO disclosed
EP-0713483-A1 AMIDINE DERIVATIVES WITH NITRIC OXIDE SYNTHETASE ACTIVITIES Astra Aktiebolag (SE) 1996-05-29 EP disclosed
WO-1996001817-A1 BICYCLIC AMIDINE DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHETASE ASTRA AKTIEBOLAG (SE) 1996-01-25 WO disclosed
WO-1994026738-A1 N'-HETEROCYCLYL-N-BENZOFURANYL UREA DERIVATIVES AND THEIR ANALOGS AS ACAT INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-24 WO disclosed
EP-0531702-A1 Process for the manufacture of insecticidal, nematicidal and acaricidal 2-aryl-3-substitued-5-(trifluoromethyl)pyrrole compounds from N-(substituted benzyl)-2,2,2-trifluoroacetimidoyl chloride compounds AMERICAN CYANAMID COMPANY (US) 1993-03-17 EP disclosed
US-5145986-A Process for the manufacture of insecticidal, nematicidal and acaricidal 2-aryl-3-substituted-5-(trifluoromethyl)pyrrole compounds from N-(substituted benzyl)-2,2,2-trifluoro-acetimidoyl chloride compounds AMERICAN CYANAMID COMPANY (US) 1992-09-08 US disclosed
EP-0181709-A1 Dichloroaniline Derivatives GLAXO GROUP LIMITED (GB) 1986-05-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160303128-A1 PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS ABL1, ERBB2, MAP3K2 RIPK1 724/4885MMP8 3036/4885HDAC3 855/4885
US-20230137943-A1 PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS PPIA, S100A4, S100A6 RIPK1 2103/4885MMP8 1273/4885HDAC3 3755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.